DrugDashboards

Tobramycin

Tobramycin · TOBRAMYCIN 3 mg/mL · Solution · Ophthalmic · Bausch & Lomb Incorporated

NDC 24208-0290-05 · 1 BOTTLE, DROPPER in 1 CARTON / 5 mL in 1 BOTTLE, DROPPER · ANDA · View full market →

The short version

23 companies supply this market — deep enough that no single failure threatens the supply. The price has held steady around $1.16 per mL over the past year. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$1.16per MLinvoice-surveyed acquisition cost · Aug 19, 2026
  • Part D plans paid (avg)$6.53per dosage unitgross, before rebates — matched by drug name · 2024
  • Federal contracts pay (FSS)$6.51per package of 5MLBausch & Lomb Americas Inc. · Jun 15, 2024
  • Medicaid generic ceiling (FUL)$1.16per MLweighted avg manufacturer price $0.6489 · Aug 1, 2026100% of what pharmacies pay — higher than 10% of drugs with this benchmark

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$1.00$2.00$3.00Nov 2013Sep 2026$1.16
155 price points · per ML · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Estimated fill cost

WAC per package, as filed
$11.75
Reported to Texas DSHS · 2026 annual filing · Bausch and Lomb Americas Inc.

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$225,846
18,793 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

0● Low risk

Nothing here is signaling trouble: several manufacturers, no current shortage, no recent serious recalls, stable pricing. In drug supply, boring is the good outcome.

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for tobramycin (other) in the next 90 days

OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $1,307.96 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA064052
TE code
AT
Approval date
Nov 29, 1993
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Tobramycin (Solution)

LabelerStrengthFirst seenLast seen
A-S Medication SolutionsTOBRAMYCIN 3 mg/mLJul 15, 2026Sep 2, 2026
Advanced Rx Pharmacy of Tennessee, LLCTOBRAMYCIN 3 mg/mLJul 15, 2026Sep 2, 2026
American Health PackagingTOBRAMYCIN 300 mg/5mLJul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals LLCTOBRAMYCIN 300 mg/5mLJul 15, 2026Sep 2, 2026
Ascend Laboratories, LLCTOBRAMYCIN 300 mg/5mLJul 15, 2026Sep 2, 2026
Asclemed USA, Inc.TOBRAMYCIN 3 mg/mLJul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedTOBRAMYCIN 300 mg/5mLJul 15, 2026Sep 2, 2026
Bausch & Lomb IncorporatedTOBRAMYCIN 3 mg/mLJul 15, 2026Sep 2, 2026
Chiesi USA, Inc.TOBRAMYCIN 300 mg/4mLJul 15, 2026Sep 2, 2026
Genericus, Inc.TOBRAMYCIN 300 mg/5mLJul 15, 2026Sep 2, 2026
Lifestar Pharma LLCTOBRAMYCIN 300 mg/5mLJul 15, 2026Sep 2, 2026
Lifestar Pharma LLCTOBRAMYCIN 300 mg/4mLJul 15, 2026Sep 2, 2026
Lupin Pharmaceuticals, Inc.TOBRAMYCIN 300 mg/5mLJul 15, 2026Sep 2, 2026
NorthStar RxLLCTOBRAMYCIN 300 mg/4mLJul 15, 2026Sep 2, 2026
NorthStar RxLLCTOBRAMYCIN 300 mg/5mLJul 15, 2026Sep 2, 2026
NuCare Pharmaceuticals,Inc.TOBRAMYCIN 3 mg/mLJul 15, 2026Sep 2, 2026
Pari Respiratory Equipment, Inc.TOBRAMYCIN 300 mg/5mLJul 15, 2026Sep 2, 2026
Ritedose Pharmaceuticals, LLCTOBRAMYCIN 300 mg/5mLJul 15, 2026Sep 2, 2026
Sandoz IncTOBRAMYCIN 3 mg/mLJul 15, 2026Sep 2, 2026
Sportpharm LLCTOBRAMYCIN 3 mg/mLJul 15, 2026Sep 2, 2026
Sun Pharmaceutical Industries, Inc.TOBRAMYCIN 300 mg/5mLJul 15, 2026Sep 2, 2026
Teva Pharmaceuticals USA, Inc.TOBRAMYCIN 300 mg/5mLJul 15, 2026Sep 2, 2026
Viatris Specialty LLCTOBRAMYCIN 300 mg/5mLJul 15, 2026Sep 2, 2026
Preferred Pharmaceuticals Inc.TOBRAMYCIN 3 mg/mLJul 18, 2026Aug 29, 2026
Proficient Rx LPTOBRAMYCIN 3 mg/mLJul 15, 2026Aug 29, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Tobramycin — NDC 24208-0290-05," retrieved September 3, 2026, https://drugdashboards.com/drug/24208029005.

Free to cite with attribution — see how the data is put together.